Eikon Therapeutics, Inc. (EIKN)

Eikon Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023
Period Ending	Feb 25, 2026	Dec 31, 2024	Dec 31, 2023
Market Capitalization	787	-	-
Enterprise Value	659	-	-
Debt / Equity Ratio	0.67	0.86	0.07
Net Debt / Equity Ratio	-0.38	-0.07	-0.85
Net Debt / EBITDA Ratio	0.48	0.07	1.57
Net Debt / FCF Ratio	0.53	0.08	1.82
Quick Ratio	8.47	3.90	13.69
Current Ratio	8.80	4.04	13.88
Return on Equity (ROE)	-	-69.35%	-
Return on Assets (ROA)	-	-32.00%	-
Return on Capital Employed (ROCE)	-50.00%	-59.90%	-53.80%
Buyback Yield / Dilution	-	-24.34%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q